FindTrial
Sign In

The effect of remote self-monitoring of blood glucose combined with the promotion and application of Internet mobile terminal (APP) on the improvement of the staged type 2 diabetes management and the success rate of blood glucose in the community

The effect of remote self-monitoring of blood glucose combined with the promotion and application of Internet mobile terminal (APP) on the improvement of the staged type 2 diabetes management and the success rate of blood glucose in the community

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016497
Enrollment
Unknown
Registered
2018-06-05
Start date
2018-06-11
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

strength group:Strengthen self-monitoring of blood glucose by Internet mobile terminal (APP)
control group:Voluntary self-monitoring of blood glucose

Sponsors

Ruijin Hospital North Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Comunity contracted type 2 diabetic patients aged 18-79 years at least 3 months in Jiading community health service center; 2. Patients with poor blood glucose control in the past 3 months (7%<HbA1c=9.5%); 3. Patients themselves or their families have smart phones and can skillfully use the designated APP; 4. The permanent resident of Jiading District; 5. Subordinated to the category of medical insurance in Jiading District; 6. Voluntary sign of informed consent.

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes, gestational diabetes mellitus or other types of diabetes mellitus; 2. Women who have been pregnant or are ready to get pregnant; 3. Patients who could not complete a follow-up of 24 months; 4. Patients who are unwilling or unable to provide informed consent; 5. Floating population.

Design outcomes

Primary

MeasureTime frame
The success rate of blood glucose;Hemoglobin A1c;—

Secondary

MeasureTime frame
Health-related quality of life (HRQOL);Health economics index;FBG (fasting blood-glucose);PBG (postprandial blood glucose);Blood lipids;Urinary Microalbumin;Body mass index (BMI);Blood Pressure;Waist Circumference;Hip Circumference;Steatohepatitis;Liver function;Kidney function;Fasting insulin (FINS);Postprandial insulin (PINS);Fasting C-peptide;Postprandial C-peptide;Insulin resistance index;Insulin secretion index;Weight;Urine albumin to creatinine ratio;Chronic complication of diabetes mellitus;Life-style;Medication;Inflammatory factors;—

Countries

China

Contacts

Public ContactChen Yuhong

Ruijin Hospital North Affiliated to Shanghai Jiaotong University School of Medicine

chenyh70@126.com+86 13761150934

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026